Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob New

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Autophagy|May 19, 2025
TRIM16 mediates secretory autophagy in head and neck cancer-associated fibroblastsThuc Ly, Bailey Pickard, Avisha Pandey, et al.
Cancer Research|May 18, 2018
Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma ProgressionDhruv Kumar, Jacob New, Vikalp Vishwakarma, et al.
Molecular Carcinogenesis|October 11, 2022
Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinomaDavid Standing, Levi Arnold, Prasad Dandawate, et al.
Nature|October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam J Grippin, Christiano Marconi, Sage Copling, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Autophagy|May 19, 2025
TRIM16 mediates secretory autophagy in head and neck cancer-associated fibroblastsThuc Ly, Bailey Pickard, Avisha Pandey, et al.
Cancer Research|May 18, 2018
Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma ProgressionDhruv Kumar, Jacob New, Vikalp Vishwakarma, et al.
Molecular Carcinogenesis|October 11, 2022
Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinomaDavid Standing, Levi Arnold, Prasad Dandawate, et al.
Nature|October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam J Grippin, Christiano Marconi, Sage Copling, et al.
Pageof 3